淋巴细胞-话题@MedSci

#淋巴细胞#

495篇内容 | 7064人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1302386, encodeId=ad70130238622, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Brit J Cancer：中性粒细胞与淋巴细胞比值对肝细胞癌患者预后和诊断的意义, objectType=article, longId=212744, objectId=8099212e44e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8099212e44e6, replyNumber=0, likeNumber=83, createdTime=2021-06-16, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8099212e44e6, moduleTitle=Brit J Cancer：中性粒细胞与淋巴细胞比值对肝细胞癌患者预后和诊断的意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8099212e44e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302385, encodeId=e1231302385c3, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Nat Commun：靶向PI3K/AKT的过度激活诱导慢性淋巴细胞白血病的细胞死亡, objectType=article, longId=212706, objectId=7958212e06d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7958212e06d6, replyNumber=0, likeNumber=72, createdTime=2021-06-15, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7958212e06d6, moduleTitle=Nat Commun：靶向PI3K/AKT的过度激活诱导慢性淋巴细胞白血病的细胞死亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7958212e06d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302384, encodeId=541c1302384c9, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Leukemia：iFCG化疗方案治疗携带IGHV突变且无TP53突变的慢性淋巴细胞白血病, objectType=article, longId=212646, objectId=63c52126468a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63c52126468a, replyNumber=0, likeNumber=70, createdTime=2021-06-13, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63c52126468a, moduleTitle=Leukemia：iFCG化疗方案治疗携带IGHV突变且无TP53突变的慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63c52126468a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302383, encodeId=e4a6130238379, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：TLR9，慢性淋巴细胞白血病的新治疗靶点！, objectType=article, longId=212576, objectId=7c4b2125e69a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c4b2125e69a, replyNumber=0, likeNumber=76, createdTime=2021-06-12, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c4b2125e69a, moduleTitle=Blood：TLR9，慢性淋巴细胞白血病的新治疗靶点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c4b2125e69a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302382, encodeId=eedd1302382c4, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Cancers：中性粒细胞/淋巴细胞比（NLR）是中期肝细胞癌（HCC）患者一线接受TACE治疗的预后指标。, objectType=article, longId=212415, objectId=b72721241538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b72721241538, replyNumber=0, likeNumber=58, createdTime=2021-06-09, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b72721241538, moduleTitle=Cancers：中性粒细胞/淋巴细胞比（NLR）是中期肝细胞癌（HCC）患者一线接受TACE治疗的预后指标。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b72721241538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302381, encodeId=2dcb13023810e, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Eur Urol Focus：单细胞转录组学揭示骨髓细胞和T淋巴细胞在佩罗尼氏病纤维化微环境中的新作用 , objectType=article, longId=211928, objectId=0fd12119283c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fd12119283c, replyNumber=0, likeNumber=80, createdTime=2021-05-29, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fd12119283c, moduleTitle=Eur Urol Focus：单细胞转录组学揭示骨髓细胞和T淋巴细胞在佩罗尼氏病纤维化微环境中的新作用 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fd12119283c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302380, encodeId=b81813023808d, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Dig Dis Sci：中性粒细胞-淋巴细胞比率较高与肝细胞癌患者死亡率增加相关, objectType=article, longId=211890, objectId=c50f211890e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c50f211890e4, replyNumber=0, likeNumber=75, createdTime=2021-05-28, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c50f211890e4, moduleTitle=Dig Dis Sci：中性粒细胞-淋巴细胞比率较高与肝细胞癌患者死亡率增加相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c50f211890e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302379, encodeId=66cb13023e984, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=JAHA：法洛四联症患儿术前淋巴细胞**计数的预后价值, objectType=article, longId=211485, objectId=5543211485ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5543211485ea, replyNumber=0, likeNumber=91, createdTime=2021-05-19, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5543211485ea, moduleTitle=JAHA：法洛四联症患儿术前淋巴细胞**计数的预后价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5543211485ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302378, encodeId=a67513023e84e, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Cell Death & Differentiation：孙强/黄红艳/刘良团队合作揭示新冠患者淋巴细胞减少症发生的新机制, objectType=article, longId=211256, objectId=3cfb21125634, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cfb21125634, replyNumber=0, likeNumber=85, createdTime=2021-05-15, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cfb21125634, moduleTitle=Cell Death & Differentiation：孙强/黄红艳/刘良团队合作揭示新冠患者淋巴细胞减少症发生的新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cfb21125634)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302377, encodeId=072313023e7aa, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=JCO：Lifileucel（一种基于肿瘤浸润性淋巴细胞的治疗）在转移性黑色素瘤的疗效和安全性, objectType=article, longId=211237, objectId=ce0a21123ee7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce0a21123ee7, replyNumber=0, likeNumber=67, createdTime=2021-05-15, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce0a21123ee7, moduleTitle=JCO：Lifileucel（一种基于肿瘤浸润性淋巴细胞的治疗）在转移性黑色素瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce0a21123ee7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302376, encodeId=8c7513023e6f4, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Br J Cancer：体重指数（BMI）和**淋巴细胞计数（ALC）：乳腺癌患者无病生存期的预测指标, objectType=article, longId=210681, objectId=28ad210681eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28ad210681eb, replyNumber=0, likeNumber=84, createdTime=2021-05-01, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28ad210681eb, moduleTitle=Br J Cancer：体重指数（BMI）和**淋巴细胞计数（ALC）：乳腺癌患者无病生存期的预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28ad210681eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302375, encodeId=91cb13023e5f3, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Allergy：鼻内皮质激素治疗对2型先天淋巴细胞的影响研究, objectType=article, longId=210273, objectId=de362102e3f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de362102e3f8, replyNumber=0, likeNumber=59, createdTime=2021-04-23, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de362102e3f8, moduleTitle=Allergy：鼻内皮质激素治疗对2型先天淋巴细胞的影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de362102e3f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302374, encodeId=8c5513023e4ce, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Brit J Cancer：体重指数和**淋巴细胞计数可预测乳腺癌患者无病生存期, objectType=article, longId=210269, objectId=f97e210269dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f97e210269dd, replyNumber=0, likeNumber=90, createdTime=2021-04-23, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f97e210269dd, moduleTitle=Brit J Cancer：体重指数和**淋巴细胞计数可预测乳腺癌患者无病生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f97e210269dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302373, encodeId=ca7c13023e3e0, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则, objectType=article, longId=209942, objectId=434e20994255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=434e20994255, replyNumber=0, likeNumber=42, createdTime=2021-04-15, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=434e20994255, moduleTitle=急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=434e20994255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302372, encodeId=cd7e13023e2b1, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle= Blood：Inotuzumab ozogamicin用于复发/难治性小儿急性淋巴细胞白血病的疗效, objectType=article, longId=209725, objectId=06c7209e2530, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06c7209e2530, replyNumber=0, likeNumber=62, createdTime=2021-04-10, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06c7209e2530, moduleTitle= Blood：Inotuzumab ozogamicin用于复发/难治性小儿急性淋巴细胞白血病的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06c7209e2530)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302371, encodeId=c74713023e1dc, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=JCEM：细菌脓毒症和COVID-19患者TSH和甲状腺激素与淋巴细胞减少之间的关系, objectType=article, longId=208872, objectId=73592088e291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73592088e291, replyNumber=0, likeNumber=72, createdTime=2021-03-24, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73592088e291, moduleTitle=JCEM：细菌脓毒症和COVID-19患者TSH和甲状腺激素与淋巴细胞减少之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73592088e291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302370, encodeId=5bb413023e06d, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率, objectType=article, longId=207858, objectId=4adc20e8585b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4adc20e8585b, replyNumber=0, likeNumber=72, createdTime=2021-03-05, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4adc20e8585b, moduleTitle=JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4adc20e8585b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302369, encodeId=9f2b130236946, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=JAMA：Blinatumomab vs 化疗用于首次复发的B细胞急性淋巴细胞白血病儿童、青少年和年轻患者, objectType=article, longId=207857, objectId=663420e857ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=663420e857ae, replyNumber=0, likeNumber=67, createdTime=2021-03-05, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=663420e857ae, moduleTitle=JAMA：Blinatumomab vs 化疗用于首次复发的B细胞急性淋巴细胞白血病儿童、青少年和年轻患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=663420e857ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302368, encodeId=b51f130236892, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Clinical Nutrition: 中性粒细胞与淋巴细胞比例高与住院的癌症患者的少肌症风险增加相关, objectType=article, longId=207555, objectId=727720e555a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=727720e555a0, replyNumber=0, likeNumber=72, createdTime=2021-02-26, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=727720e555a0, moduleTitle=Clinical Nutrition: 中性粒细胞与淋巴细胞比例高与住院的癌症患者的少肌症风险增加相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=727720e555a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302367, encodeId=e596130236e0c, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Lancet Haematol：依鲁替尼加用Ublituximab可显著提高复发性/难治性慢性淋巴细胞白血病患者的缓解率, objectType=article, longId=207517, objectId=3e5020e5170d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e5020e5170d, replyNumber=0, likeNumber=62, createdTime=2021-02-25, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e5020e5170d, moduleTitle=Lancet Haematol：依鲁替尼加用Ublituximab可显著提高复发性/难治性慢性淋巴细胞白血病患者的缓解率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e5020e5170d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞

2020-05-29

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Brit J Cancer：中性粒细胞与淋巴细胞比值对肝细胞癌患者预后和诊断的意义

2021-06-16

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Nat Commun：靶向PI3K/AKT的过度激活诱导慢性淋巴细胞白血病的细胞死亡

2021-06-15

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Leukemia：iFCG化疗方案治疗携带IGHV突变且无TP53突变的慢性淋巴细胞白血病

2021-06-13

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：TLR9，慢性淋巴细胞白血病的新治疗靶点！

2021-06-12

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Cancers：中性粒细胞/淋巴细胞比（NLR）是中期肝细胞癌（HCC）患者一线接受TACE治疗的预后指标。

2021-06-09

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Eur Urol Focus：单细胞转录组学揭示骨髓细胞和T淋巴细胞在佩罗尼氏病纤维化微环境中的新作用

2021-05-29

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Dig Dis Sci：中性粒细胞-淋巴细胞比率较高与肝细胞癌患者死亡率增加相关

2021-05-28

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

JAHA：法洛四联症患儿术前淋巴细胞**计数的预后价值

2021-05-19

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Cell Death & Differentiation：孙强/黄红艳/刘良团队合作揭示新冠患者淋巴细胞减少症发生的新机制

2021-05-15

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

JCO：Lifileucel（一种基于肿瘤浸润性淋巴细胞的治疗）在转移性黑色素瘤的疗效和安全性

2021-05-15

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Br J Cancer：体重指数（BMI）和**淋巴细胞计数（ALC）：乳腺癌患者无病生存期的预测指标

2021-05-01

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Allergy：鼻内皮质激素治疗对2型先天淋巴细胞的影响研究

2021-04-23

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Brit J Cancer：体重指数和**淋巴细胞计数可预测乳腺癌患者无病生存期

2021-04-23

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则

2021-04-15

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：Inotuzumab ozogamicin用于复发/难治性小儿急性淋巴细胞白血病的疗效

2021-04-10

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

JCEM：细菌脓毒症和COVID-19患者TSH和甲状腺激素与淋巴细胞减少之间的关系

2021-03-24

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率

2021-03-05

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

JAMA：Blinatumomab vs 化疗用于首次复发的B细胞急性淋巴细胞白血病儿童、青少年和年轻患者

2021-03-05

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Clinical Nutrition: 中性粒细胞与淋巴细胞比例高与住院的癌症患者的少肌症风险增加相关

2021-02-26

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Lancet Haematol：依鲁替尼加用Ublituximab可显著提高复发性/难治性慢性淋巴细胞白血病患者的缓解率

2021-02-25

科室
- - 订阅+
  - 更多科室
工具
服务